Drugs for ischaemic heart disease

Coxor®, mg acetylsalicylic acid, is the first and only ready to use oral liquid acetylsalicylic acid for immediate use in case of suspected acute myocardial infarction (heart attacks).

The product has been approved in a European DCP process and is marketed in Norway as an OTC (over-the-counter) drug. It’s the first drug of its kind for emergency treatment of myocardial infarction and is patented in large parts of the world.

Ischemic heart disease definition

Ischaemic Heart Disease affects about million people globally and is the leading cause of death with around 9 million fatalities annually. The product became available in Norwegian pharmacies in February

"We have long seen the potential of liquid acetylsalicylic acid in the treatment of acute myocardial infarction.

Seeing that the product works and has been well-received in the domestic market, we are very excited to launchCoxor®in Greece," says Georgios Kritsionis, Director of Portfolio Man